| BCBS Florida Coverage Guidelines | SARS-CoV-2 Monoclonal Antibodies (09-J3000-86) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Siponimod (Mayzent®) Tablets (09-J3000-35) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Subcutaneous Prophylactic Therapy for (09-J5000-12) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Teprotumumab (Tepezza®) Infusion (09-J3000-64) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Tesamorelin (Egrifta) Injection (09-J1000-32) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Tofacitinib (Xeljanz®, Xeljanz® XR) Oral (09-J1000-86) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Ublituximab-xiiy (Briumvi™) (09-J4000-45) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Wheelchairs and Wheelchair Accessories (09-E0000-35) | 2025-10-01 |
| BCBS Illinois Medical Policies | Burosumab-twza | 2025-10-01 |
| BCBS Illinois Medical Policies | Chromoendoscopy as an Adjunct to Colonoscopy | 2025-10-01 |